Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POEM Study of metformin added to standard care for gestational diabetes mellitus
NL-OMON60770Phase 3Active, not recruiting
- Sponsor
- Bethesda Diabetes Research Center
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in gestational diabetes mellitus (GDM) comparing Metformin + standard of care with Standard of care alone (2 arms). Primary endpoints: GDM Outcome Score, Maternal type 2 diabetes and 2 more. Started Jan 2025; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NL-OMON60770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60770.